obesity treatment with bariatric surgery vs glp-1 receptor agonists Drugs vs. Interest in Treatment with GLP-1
Description
2021;3:e72332
Front Endocrinol 13:945609
-(1).png?sfvrsn=c236e848_3)
The reason is a complex mix of the cost of the drug itself, GLP-1s impact on health outcomes, and the fact that most preventive health measures do not reduce federal health spending
2011A thorough QT study to evaluate the effects of singledose exenatide 10 mug on cardiac repolarization in healthy subjects
